Bryan Gilburg - China

“The TFDA is implementing this new policiy to help expedite the review process by removing applications with insufficient documentation. It will be important for manufacturers to respond quickly and accurately when feedback is received to ensure applications are not rejected.”

Bryan Gilburg

Managing Director

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

Thai FDA Implements Submission Process for Screening Application Documents

Published on: August 8th, 2022

Beginning August 1st, 2022, the Thai FDA implemented a new submission process (official announcement) that will provide an initial screening of the documents provided and a response within 15 days. The new process is applicable to all applications except for Class 1, which are auto-approved, and Fast Track applications. This comes as the TFDA implements updated processes, such as query response timelines, following the recent implementation of their new medical device regulations. This latest update addresses the initial steps the TFDA will take in the first 15 days after receiving a new application which includes Screening and Reviewing the application.  All Thai FDA applications must submitted through the e-Submission portal.

New Submission Process Overview

The process is similar to a pre-submission process but instead of confirming classification and/or grouping strategy, the TFDA’s Screening and Review will be focuses on the documents provided.

Step 1: Screening

The Screening step will check for the completeness of the documents according to the TFDA’s checklist (English). The documents uploaded must match the specified topics and if the documents are incomplete, the application will be rejected immediately. If the documents are complete, TFDA will allow the application to proceed to the Review step and the submission fee will be charged.

Step 2: Review

After the submission fee transaction has been completed, the application will be assigned to the Reviewer. During this step in the process, the reviewer will assess the documents for their correctness and evidence of safety and efficacy. Should the TFDA officer find incorrect or incomplete documentation, they will provide feedback and will allow the registrant to amend their documents in response to comments within 15 calendar days, 1 time. If the amendment cannot be made within the specified timeline, the application will be rejected. The 15 calendar days does not include any additional time required after the application has been submitted for approval by the authority as well as answering expert feedback should the application besubjected to an expert review.

For more information on the registration process in Thailand, please see our Thailand Medical Device Registration page.

Come Grow with Us

Asia Actual has an office in Singapore and Bangkok staffed by experienced, bilingual regulatory and commercial professionals to address any questions or provide support. Please contact us to explore if this new program is appropriate for your devices.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.
Read more

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.
Read more

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.
Read more